Dissemin is shutting down on January 1st, 2025

Published in

American Society of Nephrology, Clinical Journal of the American Society of Nephrology, 5(5), p. 790-797, 2010

DOI: 10.2215/cjn.04120609

Links

Tools

Export citation

Search in Google Scholar

Beneficial Effect of Rituximab in the Treatment of Recurrent Idiopathic Membranous Nephropathy after Kidney Transplantation

Journal article published in 2010 by Ben Sprangers, George Ian Lefkowitz, Scott D. Cohen, Michael Barry Stokes ORCID, Antony Valeri, Gerald B. Appel, Cheryl L. Kunis
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Green circle
Postprint: archiving allowed
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO

Abstract

Background and objectives: Recurrence of the original kidney disease after renal transplantation is an increasingly recognized cause of allograft loss. Idiopathic membranous nephropathy (iMN) is a common cause of proteinuria that may progress to ESRD. It is known that iMN may recur after kidney transplantation, causing proteinuria, allograft dysfunction, and allograft loss. Limited data regarding the frequency and treatment of recurrent iMN are available.